Search Results for: Fosamax

Featured Stories
FDA Advisors Set to Examine Metal-on-Metal Hip Implant Safety Concerns

FDA Advisors Set to Examine Metal-on-Metal Hip Implant Safety Concerns

Thousands of people with metal-on-metal hip implant devices could soon get some answers from the U.S. Food & Drug Administration (FDA) about the dangers they face. Tomorrow, the agency will convene a panel of outside medical experts to examine the safety record of metal-on-metal hip replacements, and recommend the ...

Read More

Boston Scientific Transvaginal Mesh

Tennessee Woman Alleges Boston Scientific Transvaginal Mesh Product Caused Painful Injuries

More reports of painful injuries are being linked to transvaginal mesh. This time, a Tennessee woman has filed a lawsuit against Boston Scientific over its Advantage Transvaginal Mid-Urethral Sling System.

Read More

Actos Bladder Cancer Lawsuit Filed by West Virginia Resident

Actos Bladder Cancer Lawsuit Filed by West Virginia Resident

Actos (pioglitazone) continues to be named in lawsuits alleging long-term use of the type 2 diabetes drug caused patients to develop bladder cancer. Just last week, the national law firm of Parker Waichman LLP filed suit against Takeda Pharmaceuticals on behalf of a West Virginia man who developed bladder cancer ...

Read More

Actos, Avandia May Up Risk for Diabetic Macular Edema

Actos, Avandia May Up Risk for Diabetic Macular Edema

A newly published study is raising concerns that patients who take Actos or Avandia may face an increased risk of developing diabetic macular edema, an eye disorder that can result in vision loss. The study, published in the Archives of Internal Medicine, found that type 2 diabetics who use thiazolidinediones, ...

Read More

64 More Plavix Patients File Suit Over Bleeding Side Effects

64 More Plavix Patients File Suit Over Bleeding Side Effects

Another Plavix lawsuit has been filed on behalf of 64 Plavix patients who allege bleeding side effects. Plavix (clopidogrel) is a blood thinner prescribed for the prevention of blood clots and heart attacks, and has been linked to serious side effects, such as the heart attacks and strokes it is ...

Read More

Pennsylvania Health System Proposes Comprehensive Fracking Study

Pennsylvania Health System Proposes Comprehensive Fracking Study

A proposed study would examine the health effects of hydraulic fracturing (fracking) drilling on the people living closest to active natural gas wells.

Read More

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

Toxic Nano-Particles from Failing Metal-on-Metal Hip Replacements May Pose Long-Term Health Risks

Toxic Nano-Particles from Failing Metal-on-Metal Hip Replacements May Pose Long-Term Health Risks

According to a new study, failing metal-on-metal hip implants generate toxic nano-particles that release Cobalt 2+ ions, which not only cause inflammation in surrounding tissue, but have the potential to cause long-term damage to the genetic material of cells. According to a report published by Medicalxpress.com, this “genotoxicity” could ...

Read More

FDA Panel Takes up Metal-on-Metal Hip Implant Safety Today

FDA Panel Takes up Metal-on-Metal Hip Implant Safety Today

The Food and Drug Administration (FDA) is convening a meeting starting today to help decide the future of metal-on-metal hip implants following high-profile recalls and mounting questions about their overall safety.

Read More

Canadian Warning Issued for Actos Bladder Cancer Side Effect Risk

Canadian Warning Issued for Actos Bladder Cancer Side Effect Risk

Health Canada has become the most recent national drug regulator to issue a warning about Actos and bladder cancer. Last month, the agency warned that interim results from a 10-year-study indicated that patients taking Actos for more than a year faced an increased risk of bladder cancer. Health Canada also ...

Read More

Study: Bisphosphonates Use Raises Risks for Atrial Fibrillation

bisphosphonate_atrial_fibrilation

New research has found that bisphosphonate use was tied to a significant increased risk of both atrial fibrillation (AF) and serious AF. Bisphosphonates include Fosamax (alendronate sodium), Reclast and Zometa (zoledronic acid), Boniva (ibandronate sodium), Didronel (etidronate disodium), Actonel (risedronate … Continue reading

Posted in Bisphosphonates, Pharmaceuticals |

Judge Delays Fosamax MDL “Wind-Down”

judge_delays_fosamax_lawsuit

To enable plaintiffs and Merck &  Co. Inc. time to work on a potential settlement, a New York federal judge delayed the transfer of hundreds of lawsuits that are part of a multidistrict litigation (MDL) brought over alleged jaw injuries … Continue reading

Posted in Fosamax, Pharmaceuticals |

Merck Cutting Staff Over Research Unit Re-Structure Plans

merck_cutting_staff

Drug giant, Merck, has announced plans to cut 8,500 employees as part of a restructuring meant to increase marketplace competitiveness. Over the next two years, in addition to the massive layoffs, Merck also announced that it would be implementing significant … Continue reading

Posted in Defective Medical Devices, Fosamax, Medtronic Infuse, Pharmaceuticals |

Hundreds of Fosamax Lawsuits Being Sent to Trial

fosamax_lawsuits_go_through

A federal judge just ordered hundreds of cases involved in a multidistrict litigation (MDL) brought against Merck & Co. over alleged Fosamax jaw injuries be sent for trial in courts nationwide. Fosamax is Merck’s osteoporosis medication. Drug and device manufacturers … Continue reading

Posted in Fosamax, Pharmaceuticals |

Judge Denies Merck’s Request to Force Fosamax Plaintiffs To Verify Injuries

judge_denies_merck_fosamax_verification

This week, a New York federal judge denied a request to mandate hundreds of alleged Fosamax victims to substantiate their injuries. Fosamax is manufactured by Merck & Co. U.S. District Judge John Keenan refused the request that would not only … Continue reading

Posted in Fosamax, Pharmaceuticals |

Bisphosphonate Use Linked to Barrett’s Esophagus

bisphonates_linked_tp_barrets_esophagus

A study published last month in the American Journal of Gastroenterology suggests that oral bisphosphonate use was associated with a 2.33 percent increased risk of Barretts’ esophagus, a condition that increases the risk of developing esophageal cancer. Barrett’s esophagus, a … Continue reading

Posted in Fosamax, Health Concerns, Pharmaceuticals |

Woman Alleges Bisphosphonates Led to “Dead Jaw”

actonel_dead_jaw

We’ve long been following risks associated with bisphosphonate (BP) drugs like Fosamax, Boniva, and Actonel, which are approved to treat bone-weakening diseases like osteoporosis and Paget’s disease. Cancer patients also often undergo therapy with Aredia, Zometa, and other bisphosphonate drugs … Continue reading

Posted in Bisphosphonates, Pharmaceuticals |

Judge Overrules Merck’s Bid to Boot Expert Testimony from Four Doctors in Fosamax Trial

Merck and Co. was unable to stop doctors from giving expert testimony during the New Jersey-based trial, now under way, regarding osteoporosis drug Fosamax for allegedly causing atypical femur fractures. The federal judge ruled, however, that while the plaintiff’s treating … Continue reading

Posted in Fosamax, Legal News, Pharmaceuticals |

Opening Statements Heard in Second Fosamax Femur Fracture Trial

The second Fosamax femur fracture trial is underway and involve allegations that Merck’s Fosamax (alendronate) caused femur fractures in some people. The trial began in New Jersey federal court and opening statements are being heard. The lawsuit is one of … Continue reading

Posted in Fosamax, Pharmaceuticals |

Fosamax Lawsuit Begins with Opening Remarks

Opening arguments today signaled the start of the second trial charging Merck’s Fosamax with causing femur fractures. In New Jersey federal court the focus was on the case of 58-year-old Bernadette Glynn, who says that the osteoporosis drug is part … Continue reading

Posted in Fosamax |

© 2005-2014 Parker Waichman LLP ®. All Rights Reserved.